Program |
Tytuł projektu |
Akronim |
Okres realizacji |
Wartość projektu |
Wartość dofinansowania |
Opis |
Horizon2020 |
A high-dimensional approach for unwinding immune-metabolic causes of cardiovascular disease-depression multimorbidities |
TO_AITION |
01/01/2020 - 31/12/2024 |
5 990 515 EUR |
252 000 EUR |
Zobacz opis |
EiT Health |
Airway Disease Analysis and Prevention |
ADAPT |
01/01/2019 - 31/12/2021 |
381059,00 EUR |
|
Zobacz opis |
Horizon2020 |
Alliance for Life Sciences: From Strategies to Actions in Central and Eastern Europe |
A4L_ACTIONS |
01/05/2021 - 30/04/2024 |
1 999 932,49 EUR |
146 918,75 EUR |
Zobacz opis |
COST |
CliniMARK: ‘good biomarker practice’ to increase the number of clinically validated biomarkers. |
CliniMARK |
14/03/2017 - 31/10/2021 |
|
|
Zobacz opis |
Horizon2020 |
Constructing a ‘Eubiosis Reinstatement Therapy’ for Asthma |
CURE |
01/10/2017 - 31/03/2022 |
2 971 750 EUR |
232 500 EUR |
Zobacz opis |
Erasmus+ |
Education and commitent as a strategy to fight against doping |
ECASFAD |
01/01/2021 - 31/12/2022 |
253 485 EUR |
27 900 EUR |
Zobacz opis |
EiT Health |
Epidemiology of Ageing and Dementia Prevention |
Ageing@EITHealth |
01/01/2020 - 31/12/2023 |
|
35400 EUR |
Zobacz opis |
COST |
European Network to Advance Best practices & technoLogy on medication adherencE |
ENABLE |
20/10/2020 - 19/10/2024 |
|
|
Zobacz opis |
Horizon2020 |
European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases |
EU-RESPONSE |
01/07/2020 - 30/06/2025 |
15 719 450,12 EUR |
17 125 EUR |
Zobacz opis |
Third Health Programme |
Evidence-Based Guidance to Scale-up Integrated Care in Europe |
VIGOUR |
01/01/2019 - 30/06/2022 |
3 046 025,71 EUR |
88 596 EUR |
Zobacz opis |
EiT Health |
From Scientists to Innovators for Industry |
Sci Fi |
01/01/2021 - 31/12/2021 |
|
Płatne 100 lub 500 Euro od uczestnika, zależnie od wybranego modułu |
Zobacz opis |
Third Health Programme |
Health Alliance for Prudent Prescription and Yieldof Antibiotics in a Patient-centered Perspective |
HAPPY PATIENT |
01/01/2021 - 31/12/2023 |
3 311 668 EUR |
153 042 EUR |
Zobacz opis |
Horizon2020 |
Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions |
3TR |
01/10/2019 - 31/08/2026 |
80 803 177,75 EUR |
80 600 EUR |
Zobacz opis |
National Research Center |
Improving rational prescribing for UTI in frail elderly |
ImpresU |
01/04/2018 - 31/03/2021 |
889 398 PLN |
890 398 PLN |
Zobacz opis |
EiT Health |
Innovation Days |
i-Days |
01/01/2022 - 31/12/2022 |
252 880 EUR |
10 613 EUR |
Zobacz opis |
Interreg Central Europe |
Innovation ecosystem for smart elderly care |
I CARE SMART |
01/11/2019 - 30/04/2022 |
2 593 040,6 EUR |
129 601,10 EUR |
Zobacz opis |
COST |
Leukemia Gene Discovery by data sharing, mining and collaboration |
LEGEND |
26/10/2017 - 24/04/2022 |
|
|
Zobacz opis |
Horizon2020 |
Leveraging AI based technology to transform the future of health care delivery in Leading Hospitals in Europe |
ODIN |
01/03/2021 - 31/08/2024 |
11 375 651,37 EUR |
287 262,50 EUR |
Zobacz opis |
EiT Health |
Maintaining and imPrOving the intrinSIc capaciTy Involving primary care and caregiVErs (POSITIVE) |
POSITIVE |
01/01/2019 - 31/12/2021 |
297000,00 EUR |
|
Zobacz opis |
Erasmus+ |
Network of Health Science Innovation Incubation Programs |
NetHIIP |
01/09/2019 - 31/08/2022 |
241 180 EUR |
35 345 EUR |
Zobacz opis |
EiT Health |
New ways for self-management knowledge to yield up care |
New SkyCare |
01/01/2019 - 31/12/2021 |
2,750,000 EUR |
76 000 EUR |
Zobacz opis |
Erasmus+ |
Online Adaptive International Progress Test |
OAIPT |
01/09/2018 - 31/12/2021 |
331 570 EUR |
20 353 EUR |
Zobacz opis |
Fundusze Operacyjne UE |
Opracowanie prototypów leków do zastosowania w terapii komórkowej i egzosomalnej zespołu ostrej niewydolności oddechowej wywołanej przez wirus SARS-CoV-2 |
KELI |
01/03/2021 - 01/02/2022 |
840 850 EUR |
81 000 EUR |
Zobacz opis |
Horizon2020 |
SMART LIVING HOMES – WHOLE INTERVENTIONS DEMONSTRATOR FOR PEOPLE AT HEALTH AND SOCIAL RISKS |
GATEKEEPER |
01/10/2019 - 31/03/2023 |
23 636 704,38 EUR |
516 875 EUR |
Zobacz opis |
EiT Health |
Soft bone cement for better treatment of osteoporotic fractures |
Softbone |
01/01/2020 - 31/12/2020 |
2018796 euro |
153000 EUR |
Zobacz opis |
EiT Health |
Using data to improve prostate cancer diagnostics and treatment |
OncoWatch |
01/01/2019 - 31/12/2021 |
|
75000 EUR |
Zobacz opis |